Compare Jubilant Pharmova with Biocon - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT PHARMOVA vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT PHARMOVA BIOCON JUBILANT PHARMOVA /
BIOCON
 
P/E (TTM) x 13.7 47.4 28.9% View Chart
P/BV x 2.0 5.9 34.1% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 JUBILANT PHARMOVA    BIOCON
EQUITY SHARE DATA
    JUBILANT PHARMOVA
Mar-21
BIOCON
Mar-21
JUBILANT PHARMOVA /
BIOCON
5-Yr Chart
Click to enlarge
High Rs1,047488 214.6%   
Low Rs251275 91.5%   
Sales per share (Unadj.) Rs559.159.2 944.2%  
Earnings per share (Unadj.) Rs51.87.7 671.1%  
Cash flow per share (Unadj.) Rs80.113.7 586.0%  
Dividends per share (Unadj.) Rs5.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs297.662.3 477.9%  
Shares outstanding (eoy) m159.281,200.00 13.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.26.4 18.0%   
Avg P/E ratio x12.549.4 25.4%  
P/CF ratio (eoy) x8.127.9 29.1%  
Price / Book Value ratio x2.26.1 35.6%  
Dividend payout %9.70-   
Avg Mkt Cap Rs m103,365457,350 22.6%   
No. of employees `000NANA-   
Total wages/salary Rs m21,72817,410 124.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m89,05571,058 125.3%  
Other income Rs m2986,052 4.9%   
Total revenues Rs m89,35477,110 115.9%   
Gross profit Rs m18,69913,145 142.2%  
Depreciation Rs m4,5167,151 63.2%   
Interest Rs m2,473577 428.6%   
Profit before tax Rs m12,00811,469 104.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,7642,215 169.9%   
Profit after tax Rs m8,2449,254 89.1%  
Gross profit margin %21.018.5 113.5%  
Effective tax rate %31.319.3 162.3%   
Net profit margin %9.313.0 71.1%  
BALANCE SHEET DATA
Current assets Rs m29,52576,004 38.8%   
Current liabilities Rs m10,48842,101 24.9%   
Net working cap to sales %21.447.7 44.8%  
Current ratio x2.81.8 155.9%  
Inventory Days Days13137 9.2%  
Debtors Days Days3463 53.7%  
Net fixed assets Rs m58,109106,142 54.7%   
Share capital Rs m1596,000 2.7%   
"Free" reserves Rs m47,24868,728 68.7%   
Net worth Rs m47,40774,728 63.4%   
Long term debt Rs m25,64029,616 86.6%   
Total assets Rs m87,634182,146 48.1%  
Interest coverage x5.920.9 28.0%   
Debt to equity ratio x0.50.4 136.5%  
Sales to assets ratio x1.00.4 260.5%   
Return on assets %12.25.4 226.6%  
Return on equity %17.412.4 140.4%  
Return on capital %19.811.5 171.7%  
Exports to sales %00-   
Imports to sales %10.27.2 143.1%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m9,1175,084 179.3%   
Fx inflow Rs m11,20711,791 95.0%   
Fx outflow Rs m9,1175,084 179.3%   
Net fx Rs m2,0906,707 31.2%   
CASH FLOW
From Operations Rs m17,84311,597 153.9%  
From Investments Rs m-7,390-36,247 20.4%  
From Financial Activity Rs m-17,09425,640 -66.7%  
Net Cashflow Rs m-7,289723 -1,008.1%  

Share Holding

Indian Promoters % 46.5 39.7 117.1%  
Foreign collaborators % 4.2 20.9 19.9%  
Indian inst/Mut Fund % 24.2 23.2 104.3%  
FIIs % 23.1 15.7 147.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.3 39.4 125.3%  
Shareholders   113,776 363,447 31.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT PHARMOVA With:   DENIS CHEM LAB  BAL PHARMA  VENUS REMEDIES  GLENMARK PHARMA  BLISS GVS PHARMA  



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

JUBILANT PHARMOVA 2020-21 Annual Report Analysis (Annual Result Update)

Nov 8, 2021 | Updated on Nov 8, 2021

Here's an analysis of the annual report of JUBILANT PHARMOVA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT PHARMOVA . Also includes updates on the valuation of JUBILANT PHARMOVA .

BIOCON Announces Quarterly Results (2QFY22); Net Profit Up 4.9% (Quarterly Result Update)

Oct 26, 2021 | Updated on Oct 26, 2021

For the quarter ended September 2021, BIOCON has posted a net profit of Rs 2 bn (up 4.9% YoY). Sales on the other hand came in at Rs 18 bn (up 5.2% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT PHARMOVA SHARE PRICE


Dec 3, 2021 (Close)

TRACK JUBILANT PHARMOVA

  • Track your investment in JUBILANT PHARMOVA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT PHARMOVA

JUBILANT PHARMOVA 5-YR ANALYSIS

COMPARE JUBILANT PHARMOVA WITH

MARKET STATS